1. Introduction {#sec1}
===============

Early treatment of class II malocclusion aims to correct the sagittal relationship, modify the pattern of facial growth, and improve both hard- and soft-tissue profile \[[@B1]--[@B4]\]. The majority of the clinical studies recognize the useful effect of functional appliances in sagittal correction of the malocclusion but agree that the treatment is mainly restricted to dentoalveolar changes \[[@B5]\]. Favorable skeletal changes which can modify the growth pattern can also occur depending on individual growth potential \[[@B1], [@B6]\].

A class II malocclusion may result from mandibular deficiency, maxillary excess, or combination of both \[[@B7], [@B8]\]. Several varieties of functional appliances are currently in use aiming to correct the skeletal imbalances. The combination of an activator with headgear (AH) is used to provide greater cumulative skeletal changes than either appliance would provide alone \[[@B9]\]. They affect maxilla by decreasing forward and downward growth of the maxillary complex, while allowing the forward growth of the mandible to continue, thus influencing the profile more favorably \[[@B9], [@B10]\]. Twin Block (TB) appliance as well as most of other functional appliances is designed to encourage adaptive skeletal growth by maintaining the mandible in a corrected forward position for a sufficient period of time \[[@B1], [@B4], [@B11]\].

Many studies have investigated the effect of AH and TB appliance on the dental and skeletal variables. However, no studies have provided a direct comparison of the treatment changes between them. One study compared the effects of both appliances \[[@B3]\], but the evaluation was limited to the soft-tissue profile changes.

Therefore, the aims of this study were to explore skeletal and dentoalveolar changes in class II division 1 patients treated with TB and AH and to compare their treatment effect with normal growth changes of untreated controls (CTRL) with the same malocclusion. The hypotheses were as follows:Both appliances have more pronounced dentoalveolar effect in the treated groups than growth itself in the untreated group.TB stimulates more skeletal growth of mandible than AH.AH has better control of vertical dimension than TB.

2. Materials and Methods {#sec2}
========================

2.1. Study Population and Design {#sec2.1}
--------------------------------

The sample included 50 subjects (56% females) aged 8--13 years (median 11) with class II division 1 malocclusion treated with either AH (*n* = 25) or TB (*n* = 25) appliances. The data were collected retrospectively among 151 subjects treated in the period of 2000--2015 at the Department of Orthodontics in Oslo, Norway, and the Department of Orthodontics in Rijeka, Croatia. Inclusion criteria were distal molar occlusion, overjet (OJ) \>5 mm, and having pre- and posttreatment lateral cephalograms. According to the cervical vertebral maturation method \[[@B12]\], the included subjects were in the prepeak stages (CS1--CS3) of skeletal maturation before treatment and CS3--CS5 after treatment.

The AH appliance had all maxillary teeth covered with acrylic and included labial spring for the torque control of the incisors \[[@B13]\]. High pull headgear was always used simultaneously with the appliance. TB appliance \[[@B14]\] with addition of maxillary labial bow to aid the anterior retention and make the maxillary incisors retroclined was used in the other group. The expansion screw was incorporated in the maxillary plate and activated one quarter-turn each week for an average period of six months. Construction bite was the same in both appliances with the anterior positioning of mandible by 6 mm and vertical opening by 4 mm in the first molar area. The patients were recommended to use the appliances for 12--14 hours per day. Treatment was stopped when the patients achieved molar class I occlusion or slight hypercorrection.

Pretreatment (T1) and posttreatment (T2) lateral cephalograms were evaluated and compared to 50 untreated class II division 1 cases matched by age, gender, ANB angle, skeletal maturation of cervical vertebrae, and observation period. They were selected from American Association of Orthodontists Foundation Craniofacial Growth Legacy Collection. Cephalometric analysis ([Table 1](#tab1){ref-type="table"}, [Figure 1](#fig1){ref-type="fig"}) was performed on calibrated pre- and posttreatment lateral cephalograms by two investigators (KMT and SS) using the cephalometric software Facad (Ilexis AB, Sweden) and AudaxCeph (Audax, Slovenia).

The study was in accordance with the Helsinki Declaration and the protocol was approved by the local ethical committees in Norway (02-09-2010) and in Croatia (2170-24-01-15-2).

2.2. Statistical Analysis {#sec2.2}
-------------------------

After inspection of histograms and quantile-quantile plots and testing the normality of the data with the Shapiro-Wilk test, a paired *t*-test was preformed to assess the statistical significance of changes occurring during the treatment with each appliance (intragroup analysis). Independent samples test was used for intergroup analysis (between appliances groups). For the differences in age between groups, the Kruskal-Wallis test was used and *χ*^2^ for differences in gender. Analysis of variance with the Student-Newman-Keuls post hoc test was used to test the amount of changes between treated groups and controls. Effect size, that is, the magnitude of the relationship, was estimated by *r* and *η*^2^. Discriminant function analysis, a multivariate technique, was used to explore which changes in cephalometric parameters discriminate treatment groups and untreated subjects the most, and how effective those parameters are in predicting treatment group membership.

Reliability, that is, consistency of measurements, was assessed on ten randomly selected cephalograms remeasured with a three-month interval. Intraclass correlation coefficient (ICC) and Dahlberg formula were used. Dahlberg formula for method error is ME = ∑*d*^2^/2*n*, where "*d*" is the difference between two registrations and "*n*" is the number of double registrations \[[@B15]\]. IBM SPSS 22 (IBM Corp, Armonk, USA) software was used for data analysis.

3. Results {#sec3}
==========

The reliability of measurements was good or excellent, with ICC ranging from 0.660 for upper-to-lower facial height ratio to 0.995 for inclination of mandibular plane relative to the anterior cranial base and ME from 0.3 for SNA to 6.6 for nasolabial angle. The error of the method was less than 10% of the biologic variation. Power calculation of this study showed the least detectable mean difference in diff ANB to be 1.1 degree (80% test power with 95% significance level). The present study was not suitable for statistical analysis of gender differences in treatment effects due to small samples.

At T1, the treatment groups had similar characteristics (Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}), and differences between genders in those variables were not significant. Untreated subjects had lower OJ at T1 (5.6 ± 2.1; *p* \< 0.001), but higher OJ at T2 (5.9 ± 2.2; *p* \< 0.001) compared to the treated groups.

Treatment with both appliances resulted in significant increase of the SNB angle, reduction of the ANB angle, retrusion and retroclination of the maxillary incisors, protrusion and proclination of the mandibular incisors, and reduction of the OJ ([Table 3](#tab3){ref-type="table"}). Soft tissues demonstrated reduction of convexity and prominence of the upper lip and increased nasolabial angle.

The untreated group manifested significant increase in the SNB angle (*p* = 0.005), upper and lower facial height (*p* ≤ 0.001), and increased maxillary and mandibular length (*p* \< 0.001), with the mandible growing significantly more than the maxilla ([Table 4](#tab4){ref-type="table"}).

Treatment with the TB appliance resulted in increased mandibular incisor proclination and protrusion compared to the AH appliance (*p* \< 0.05; [Table 5](#tab5){ref-type="table"}).

Treatment with both functional appliances resulted in significant reduction of the ANB angle when compared to the untreated population (*p* \< 0.001; [Table 5](#tab5){ref-type="table"}). It was mainly due to the increase in the SNB angle and maxillomandibular differential length (difference between effective mandibular length (Co-Gn) and the effective midface length (Co-A); *p* \< 0.001). Both appliances significantly reduced the convexity of the hard and soft facial tissues in comparison to the untreated population (*p* \< 0.001). Additionally, retroclination of the maxillary incisors was noticed in both treatment groups and was slightly but insignificantly more pronounced in the AH group. Proclination of the mandibular incisors was significantly more pronounced in the TB group (*p* \< 0.05). As a consequence, OJ and the prominence of the upper lip were significantly reduced in comparison to the untreated subjects (*p* \< 0.001).

In order to explore which variables mostly distinguish the three groups of subjects, discriminant analysis was applied. Changes in cephalometric variables during treatment and observation period were used as predictors. Variables that demonstrated most changes or differences were selected, with special attention in obtaining the lowest possible correlation between predictors. Two discriminant functions in this analysis could be estimated, both having significant discriminating power. [Figure 2](#fig2){ref-type="fig"} demonstrates that functions clearly discriminate groups. First discriminant function, presented in horizontal direction of [Figure 2](#fig2){ref-type="fig"}, distinguishes treated from untreated subjects. Variables that comprise this first discriminant function are presented in [Table 6](#tab6){ref-type="table"} and their correlations with the first discriminant function are marked with asterisks in the first numeric column. More effect size was seen in the position of the incisors and soft tissues than in the skeletal changes. Changes in those features explained high proportion of variability of distinction between treated and untreated subjects (90.9%; *p* \< 0.001).

Second discriminant function, presented in vertical direction of [Figure 2](#fig2){ref-type="fig"} and marked in the last column of [Table 6](#tab6){ref-type="table"}, mostly distinguishes the two treatment groups. More effect size was seen in inclination of incisors and mandibular growth than in the position of the lower lip. Changes in those features accounted for low variability of distinction between treatment groups (9.1%; *p* = 0.041). Discriminant analysis correctly classified 79% of the subjects. Correct group membership was retained in 96% untreated subjects, 72% of TB, and 52% of AH group.

4. Discussion {#sec4}
=============

Both TB and AH functional appliances successfully reduced the severity of class II malocclusion by a combination of dental and skeletal changes. Overjet, SNB, and ANB angles were significantly improved in both groups. All of these changes were significantly different from the changes in the untreated, control group suggesting positive treatment effect with functional appliances. The only variables that exhibited significant differences between the two appliances after the treatment were the proclination and the protrusion of the mandibular incisors, which were more pronounced in the TB group.

The SNB angle significantly increased in both treatment groups, which is in agreement with other studies \[[@B8], [@B13], [@B16]\]. However, these changes, particularly in the TB group, were smaller than the previously reported and could be related to the concomitant increase in the lower anterior facial height, lower incisor proclination, and posterior displacement of point B \[[@B14]\].

Great variability in increase in effective mandibular length, that is, Co-Gn, is demonstrated, particularly in AH group. The effective mandibular length increased mostly in the TB group which is supported by numerous investigations \[[@B2], [@B5], [@B8]\]. The amount of mean increase in mandibular length in the AH group is similar to normal mandibular growth of untreated class II division 1 cases. Supplementary mandibular length growth of 2.5 mm in the TB subjects in comparison to untreated subjects in this study corresponds with the results reported in a recent meta-analysis \[[@B17]\]. One of the several systematic reviews on the treatment effect of removable functional appliances reported that short-term evidence suggested mainly dentoalveolar rather than skeletal effects; however, the skeletal changes were more pronounced with the TB appliance \[[@B5]\]. The most recent meta-analysis revealed more supplementary mandibular growth in pubertal than prepubertal class II malocclusion patients treated with functional appliances \[[@B18]\]. Therefore, treatment timing, as well as individual differences in treatment response, may give a plausible explanation for the reported discrepancies.

Both appliances in the current study had little, insignificant restraining effect on the maxilla. Several investigations have previously reported that forward growth of the maxilla may be inhibited during AH treatment \[[@B4], [@B9], [@B10], [@B16]\]. Others could not confirm this effect \[[@B13], [@B19]\]. Restricted forward growth of maxilla in patients treated with TB is found in most of the studies included in the systematic review by Ehsani et al. \[[@B17]\]. The labial bow used to increase retention and control the maxillary incisors in the TB appliance might have made the maxillary incisors retroclined, made the roots proclined, and affected the position of the A point \[[@B11]\]. Thus, it is possible that the restraining effect on maxilla was more pronounced but was underestimated due to a forward movement of the A point. The increased SNA angle in the control group is also in support of this notion.

The ANB angle showed higher decrease in both treatment groups in comparison to the untreated controls. The significant change in the TB group was mainly due to the significant skeletal mandibular effect concerning both angular and linear measurements. In the AH group, the nature of the ANB changes is controversial and could be a combination of dentoalveolar and skeletal changes in both jaws. Some studies indicate that reduction of the ANB angle is mainly due to a delayed forward growth of maxilla, while some report that reduced ANB angle is more dependent on increased mandibular growth \[[@B16]\]. Regardless of the treatment changes that lead to reduction in the ANB angle, the same effect could not be demonstrated in the control group. This finding further supports the fact that there is no self-correction of class II malocclusion and that functional treatment is beneficial for the patient.

Several authors underline the importance of keeping control of the vertical dimensions while correcting sagittal discrepancies \[[@B16], [@B20]\]. This is an imperative in patients with a tendency for posterior rotation of the mandible. Treatment with activator without a headgear showed effective condylar growth and change in chin position; however, these changes were not in the desired sagittal direction, rather in the vertical one \[[@B21]\]. In the present study, the effects of the two appliances on vertical measurements are similar; still, the AH appliance seemed to have some tendency to control the vertical dimension by promoting anterior rotation of the mandible and this is a consistent finding \[[@B7], [@B9], [@B19], [@B22]\]. Posttreatment changes in mandibular plane inclination were not observed in the TB group. This is in accordance with most studies; however, an increased mandibular plane inclination has also been reported \[[@B23], [@B24]\]. It should be emphasized that individual growth pattern varies and must be seen as an important factor contributing to the divergent treatment response.

Dentoalveolar changes played a dominant role in class II malocclusion correction in both groups, which is in agreement with other reports \[[@B11], [@B13]\]. Retroclination of maxillary incisors is a consistent finding in many other TB \[[@B2], [@B6], [@B8]\] and AH studies \[[@B9], [@B16], [@B19]\]. A more pronounced retrusion of the upper incisors was found in the AH group, which may reflect the additional headgear forces acting posteriorly on the maxillary apical base and alveolar structures. Retroclination and retrusion of prominent maxillary incisors may have a preventive effect since large overjet doubles the risk of dental trauma \[[@B25]\]. The most prominent dentoalveolar effect in the TB group was proclination and protrusion of the mandibular incisors compared to the AH group. Changes in the inclination of the lower incisors in functional appliances studies are contradictory and probably not sufficiently controlled by their capping with acrylic \[[@B8], [@B13], [@B18], [@B22]\].

At the end of the treatment, both treatment groups showed similar reduction of the profile convexity and retrusion of the upper lip. These results are in agreement with previous studies \[[@B9], [@B16], [@B24], [@B26], [@B27]\]. However, retrusion of the lip relative to the nose-chin line may reflect growth of the nose but also more forward chin position induced by functional treatment. It should also be noted that there is a large variation in treatment response for most of the soft-tissue parameters and sometimes the magnitude of the changes may not be perceived as clinically significant \[[@B28]\].

The discriminant analysis revealed that there was a greater difference between the control group and the two treated groups than that between the TB and AH group. The majority of the changes could be attributed to treatment with either of the two appliances, but the treatment effect was more dentoalveolar than skeletal compared to the controls.

5. Conclusions {#sec5}
==============

Both AH and TB appliances contributed successfully to the correction of class II division 1 malocclusion when compared to the untreated growing class II subjects producing predominantly dentoalveolar effects. TB appliance leads to more pronounced protrusion and proclination of the mandibular incisors than the AH group. Treatment with TB results in some supplementary mandibular length growth while AH exerted some tendency to more control of the vertical dimension of the lower anterior facial height. Normal growth pattern in untreated class II subjects comprises forward and downward growth displacement of the maxilla and the mandible without major changes in basal sagittal relation between the jaws. Clinical relevance of these findings is that early treatment may correct or at least ameliorate class II division I malocclusion which is not self-corrective.
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![Points and plains used in cephalometric analysis: Gl′ (soft-tissue glabella), Prn (pronasale), Cm (columella), Sn (subnasale), Ls (labrale superius), Li (labrale inferius), Pg′ (soft-tissue pogonion), Pg (osseous pogonion), Gn (gnathion), Me (menton), Go (gonion), Ba (basion), Co (condylion), Po (porion), Pt (pterygoid point), S (sella), PNS (posterior nasal spine), ANS (anterior nasal spine), N (nasion), Or (orbitale), Ap + 1 (apicale superius), Ap − 1 (apicale inferius), In + 1 (incisale superius), In − 1 (incisale inferius), NSL (nasion-sella line), FA (facial axis), NL (nasal line), MP (mandibular plane), FH (Frankfort horizontal), E (Ricketts\' Esthetic line), and S (Steiner\'s line).](BMRI2017-4861924.001){#fig1}
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###### 

Cephalometric variables used in the study.

  Number   Variable           Unit   Description
  -------- ------------------ ------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1        NSBa               °      Cranial base angle expression of the flexion of the cranial base (nasion-sella-basion)
  2        SNA                °      Angle of anterior part of cranial base (S-N) and point A (subspinale) on maxilla
  3        SNB                °      Angle of anterior part of cranial base (S-N) and point B (supramentale) on mandible
  4        ANB                °      Angle between point nasion and point on maxilla and mandible, basal sagittal relation between the jaws
  5        A-NPg              mm     The shortest distance from A point to the facial plane (N-Pg), expression of the skeletal convexity of the face
  6        NL/NSL             °      Angle between the nasal line (anterior to posterior nasal spine ANS-PNS) and the nasion-sella line, expression of the tilting of the maxilla relative to the anterior cranial base
  7        MP/NSL             °      Angle of mandibular plane (Go-Me) relative to the anterior cranial base
  8        MP/NL              °      Angle of mandibular plane (Go-Me) and nasal line
  9        FA/NBa             °      Lower angle between the facial axis (pterygoid point-gnathion) and the nasion-basion line, expression of the growth direction of the chin and the relationship, facial height and depth
  10       UFH                mm     Upper facial height (middle third of the face), distance from nasion point to spina nasalis anterior measured perpendicular to Frankfort horizontal (FH)
  11       LFH                mm     Lower facial height (lower third of the face), distance from spina nasalis anterior to menton measured perpendicular to FH
  12       UFH/LFH            \%     Upper to lower facial height ratio
  13       Co-A               mm     Distance from condylion to A point; measurement of the effective length of midface
  14       Co-Gn              mm     Distance from condylion to gnathion; measurement of the effective length of mandible
  15       Max Mand diff      mm     Maxillomandibular differential length, the difference between the effective mandibular length (Co-Gn) and the effective midface length (Co-A): gives an indication of the sagittal discrepancy between maxilla and mandible
  16       −1/MP              °      Superoposterior angle of lower incisor long axis and mandibular plane
  17       +1/NSL             °      Inferoposterior angle of upper incisor long axis and a nasion-sella line
  18       −1/A-Pg angle      °      Angle between the long axis of the lower incisor and A-Pg line
  19       +1/A-Pg angle      °      Angle between the long axis of the upper incisor and A-Pg line
  20       −1/A-Pg distance   mm     Distance from the midpoint of the incisal edge of the most prominent mandibular incisor to A-Pg line, expression of the protrusion of the lower incisors
  21       +1/A-Pg distance   mm     Distance from the midpoint of the incisal edge of the most prominent maxillary incisor to A-Pg line, expression of the protrusion of the upper incisors
  22       Gl′-Sn-Pg′         °      Lower angle formed by the line from glabella to subnasale and the line from soft tissue pogonion to subnasale, expression of the convexity of the soft tissue profile
  23       Cm-Sn-Ls           °      Nasolabial angle, expression of dentoalveolar protrusion
  24       Li-E               mm     Distance from lower lip (labrale inferius) to Prn-Pg′ (Ricketts\' Esthetic line)
  25       Ls-E               mm     Distance from upper lip (labrale superius) to Prn-Pg′ (Ricketts\' Esthetic line)
  26       Li-S               mm     Distance from lower lip to Cm-Pg′ (Steiner\'s line)
  27       Ls-S               mm     Distance from upper lip to Cm-Pg′ (Steiner\'s line)
  28       OJ                 mm     Distance between the incisal edges of the most prominent maxillary and mandibular incisors, measured parallel to the occlusal line

###### 

Gender, age, and treatment duration of the Twin Block (TB), Activator headgear (AH) and untreated, control (CTRL) group.

                                     Treatment group   *p*                       
  ---------------------------------- ----------------- ------------ ------------ --------------
  Female gender (*N*; percentage)    15 (60)           13 (52)      28 (56)      0.850^*∗*^
  Age before treatment (years)                                                    
   Median (interquartile range)      11 (10--12)       10 (9--11)   11 (10-11)   0.336^*∗∗*^
   Min--max                          9--13             8--12        8--13         
  Mean observation period (months)                                                
   Mean ± std. deviation             14.2 ± 4.8        15.4 ± 5.5   14.9 ± 5.2   0.745^*∗∗∗*^
   Min--max                          8--24             12--24       10--24        

^*∗*^ *χ* ^2^ test. ^*∗∗*^Kruskal-Wallis test. ^*∗∗∗*^ANOVA.

###### 

Pretreatment (T1) and posttreatment (T2) values of the investigated variables in the Twin Block (TB) and activator-headgear (AH) groups.

                     TB             *p* ^*∗*^      *r* ^*∗∗*^    AH      *p* ^*∗*^      *r* ^*∗∗*^                   
  ------------------ -------------- -------------- ------------- ------- -------------- -------------- ------------- -------
  NSBa               131.0 ± 4.5    130.9 ± 4.6    0.752         0.065   128.3 ± 5.1    127.4 ± 5.0    **0.014**     0.476
  SNA                80.1 ± 3.2     79.8 ± 3.6     0.118         0.315   81.8 ± 2.8     81.7 ± 2.7     0.432         0.161
  SNB                74.2 ± 3.0     75.3 ± 3.3     **\<0.001**   0.751   76.2 ± 2.5     77.4 ± 2.5     **\<0.001**   0.835
  ANB                5.9 ± 1.6      4.4 ± 1.7      **\<0.001**   0.751   5.7 ± 1.7      4.2 ± 1.7      **\<0.001**   0.899
  A-NPg              4.9 ± 2.1      3.7 ± 2.3      **\<0.001**   0.661   4.2 ± 2.2      2.9 ± 2.4      **\<0.001**   0.831
  NL/NSL             7.9 ± 2.9      7.6 ± 3.1      0.359         0.187   5.4 ± 2.5      5.2 ± 2.6      0.420         0.165
  MP/NSL             35.2 ± 4.7     35.3 ± 5.2     0.925         0.019   33.3 ± 5.0     32.4 ± 4.7     **0.011**     0.488
  MP/NL              27.3 ± 4.5     27.7 ± 4.8     0.431         0.162   27.9 ± 4.6     27.2 ± 4.6     0.086         0.343
  FA/NBa             86.1 ± 3.4     86.3 ± 3.7     0.614         0.104   87.5 ± 3.7     87.8 ± 4.0     0.299         0.212
  UFH                47.7 ± 3.0     49.3 ± 3.4     **0.001**     0.597   46.2 ± 4.8     46.7 ± 3.3     0.534         0.128
  LFH                56.8 ± 4.5     59.9 ± 4.7     **\<0.001**   0.784   57.3 ± 5.7     58.8 ± 4.4     0.154         0.288
  UFH/LFH            84.4 ± 8.0     82.8 ± 7.2     **0.014**     0.474   80.7 ± 4.9     79.6 ± 5.3     0.157         0.286
  Co-A               81.0 ± 5.3     83.0 ± 4.3     **0.016**     0.467   83.0 ± 8.2     82.6 ± 4.2     0.799         0.053
  Co-Gn              99.9 ± 6.1     105.0 ± 6.3    **\<0.001**   0.768   102.6 ± 10.4   105.1 ± 6.0    0.162         0.283
  Max Mand diff      18.9 ± 3.1     22.0 ± 4.3     **\<0.001**   0.743   19.6 ± 3.6     22.4 ± 3.5     **\<0.001**   0.784
  −1/MP              97.7 ± 7.4     100.7 ± 7.4    **0.002**     0.572   95.5 ± 7.6     96.1 ± 6.4     0.456         0.153
  +1/NSL             107.6 ± 7.1    100.5 ± 6.4    **\<0.001**   0.803   110.1 ± 6.7    102.7 ± 6.3    **\<0.001**   0.772
  −1/A-Pg angle      22.0 ± 5.8     27.5 ± 5.2     **\<0.001**   0.765   21.0 ± 7.3     23.7 ± 5.1     **0.002**     0.583
  +1/A-Pg angle      38.5 ± 5.5     28.9 ± 4.7     **\<0.001**   0.893   37.9 ± 5.6     27.5 ± 5.2     **\<0.001**   0.867
  −1/A-Pg distance   0.3 ± 2.0      2.6 ± 1.7      **\<0.001**   0.875   0.0 ± 2.3      1.4 ± 2.0      **\<0.001**   0.775
  +1/A-Pg distance   9.3 ± 1.9      6.4 ± 1.9      **\<0.001**   0.915   9.2 ± 2.0      5.6 ± 2.0      **\<0.001**   0.861
  Gl′-Sn-Pg′         20.3 ± 5.3     18.2 ± 5.6     **0.002**     0.583   18.5 ± 5.8     16.4 ± 5.2     **0.002**     0.586
  Cm-Sn-Ls           116.9 ± 11.9   118.1 ± 10.2   0.589         0.111   107.7 ± 8.5    113.8 ± 11.3   **0.005**     0.533
  Li-E               0.1 ± 2.5      −0.5 ± 2.5     0.120         0.313   −0.6 ± 3.5     −1.5 ± 2.8     **0.020**     0.455
  Ls-E               −0.5 ± 2.0     −2.2 ± 2.0     **\<0.001**   0.701   −0.1 ± 2.2     −1.9 ± 2.4     **\<0.001**   0.823
  Li-S               1.1 ± 2.4      0.7 ± 2.3      0.327         0.200   0.7 ± 3.3      −0.1 ± 2.8     0.050         0.389
  Ls-S               1.3 ± .7       −0.2 ± 1.6     **\<0.001**   0.661   2.0 ± 2.0      0.1 ± 2.2      **\<0.001**   0.861
  OJ                 9.0 ± 2.5      3.8 ± 1.8      **\<0.001**   0.956   9.2 ± 2.3      4.3 ± 1.9      **\<0.001**   0.888

^*∗*^Paired samples *t*-test.

^*∗∗*^Effect size calculated by using the formula *r* = √*t*^2^/(*t*^2^ + *df*). Cohen criteria for interpretation of effect size were used: *r* = 0.1--0.3 = small effect size, 0.3--0.5 = medium, and \>0.5 = large.

###### 

Mean values of the investigated variables in the untreated, control group at the same pretreatment (T1) and posttreatment (T2) age as the treated groups.

                     T1             T2            *p* ^*∗*^     *r* ^*∗∗*^
  ------------------ -------------- ------------- ------------- ------------
  NSBa               130.9 ± 4.2    130.7 ± 4.7   0.514         0.093
  SNA                82.1 ± 2.4     82.4 ± 2.5    0.174         0.193
  SNB                75.8 ± 2.8     76.3 ± 2.6    **0.005**     0.384
  ANB                6.3 ± 2.0      6.0 ± 1.9     0.204         0.181
  A-NPg              5.2 ± 2.0      5.1 ± 2.1     0.479         0.101
  NL/NSL             6.6 ± 3.3      6.7 ± 3.5     0.772         0.042
  MP/NSL             35.0 ± 4.8     34.9 ± 5.0    0.625         0.070
  MP/NL              28.4 ± 5.0     28.2 ± 5.3    0.526         0.091
  FA/NBa             87.9 ± 4.3     88.2 ± 4.2    0.304         0.147
  UFH                46.3 ± 3.1     47.6 ± 3.4    **\<0.001**   0.581
  LFH                56.5 ± 5.2     57.9 ± 6.0    **0.001**     0.463
  UFH/LFH            82.3 ± 6.6     82.8 ± 7.3    0.535         0.089
  Co-A               81.3 ± 4.9     82.7 ± 5.3    **\<0.001**   0.512
  Co-Gn              99.8 ± 5.9     102.4 ± 6.4   **\<0.001**   0.761
  Max Mand diff      18.5 ± 3.2     19.7 ± 4.0    **0.001**     0.461
  −1/MP              97.8 ± 5.5     96.9 ± 5.5    0.105         0.230
  +1/NSL             102.7 ± 7.2    103.1 ± 7.2   0.487         0.100
  −1/A-Pg angle      22.7 ± 5.1     22.5 ± 5.2    0.708         0.054
  +1/A-Pg angle      32.8 ± 6.7     32.4 ± 6.8    0.345         0.135
  −1/A-Pg distance   1.3 ± 2.3      1.2 ± 2.4     0.749         0.046
  +1/A-Pg distance   6.9 ± 2.2      7.1 ± 2.7     0.144         0.207
  Gl′-Sn-Pg′         16.4 ± 4.4     16.8 ± 4.3    0.258         0.161
  Cm-Sn-Ls           110.0 ± 13.9   112.9 ± 9.6   **0.037**     0.293
  Li-E               1.4 ± 2.2      1.1 ± 2.3     0.270         0.157
  Ls-E               0.4 ± 2.2      −0.1 ± 2.1    **0.017**     0.334
  Li-S               2.3 ± 2.2      2.2 ± 2.3     0.783         0.039
  Ls-S               2.1 ± 2.0      2.0 ± 2.2     0.829         0.031
  OJ                 5.6 ± 2.1      5.9 ± 2.2     0.068         0.258

^*∗*^Paired samples *t*-test.

^*∗∗*^Effect size.

###### 

Comparison of the treatment changes (Δ) in the Twin Block (TB) and activator-headgear (AH) group and untreated controls (CTRL).

                     ΔTB             ΔAH              ΔCTRL           *p* ^*∗*^     *η* ^2*∗∗*^
  ------------------ --------------- ---------------- --------------- ------------- -------------
  NSBa               −0.1 ± 2.1      −0.9 ± 1.6       −0.2 ± 2.1      0.313         0.024
  SNA                −0.4 ± 1.2      −0.2 ± 1.2       0.3 ± 1.5       0.087         0.049
  SNB                1.1 ± 1.0       1.2 ± 0.8        0.6 ± 1.3       **0.036**     0.066
  ANB                −1.5 ± 1.3^a^   −1.4 ± 0.7^a^    −0.3 ± 1.5^b^   **\<0.001**   0.179
  A-NPg              −1.2 ± 1.3^a^   −1.3 ± 0.9^a^    −0.1 ± 1.4^b^   **\<0.001**   0.161
  NL/NSL             −0.4 ± 1.9      −0.3 ± 1.6       0.1 ± 2.1       0.588         0.011
  MP/NSL             −0.0 ± 1.7      −0.9 ± 1.7       −0.1 ± 2.1      0.138         0.040
  MP/NL              0.4 ± 2.4       −0.7 ± 1.9       −0.2 ± 2.6      0.283         0.026
  FA/NBa             0.2 ± 2.0       0.3 ± 1.5        0.3 ± 2.0       0.976         0.001
  UFH                1.6 ± 2.2       0.5 ± 4.0        1.3 ± 1.9       0.295         0.025
  LFH                3.0 ± 2.4       1.5 ± 5.1        1.4 ± 2.6       0.119         0.043
  UFH/LFH            −1.7 ± 3.2      −1.1 ± 3.8       0.5 ± 5.8       0.134         0.041
  Co-A               2.0 ± 3.9       −0.3 ± 6.7       1.4 ± 2.4       0.114         0.044
  Co-Gn              5.1 ± 4.4       2.5 ± 8.6        2.6 ± 2.2       0.086         0.049
  Max Mand diff      3.1 ± 2.9^a^    2.8 ± 2.3^a^     1.1 ± 2.2^b^    **0.001**     0.126
  −1/MP              3.0 ± 4.4^a^    0.5 ± 3.6^b^     −0.9 ± 3.8^b^   **\<0.001**   0.145
  +1/NSL             −7.0 ± 5.3^a^   −7.3 ± 6.2^a^    0.4 ± 4.0^b^    **\<0.001**   0.378
  −1/A-Pg angle      5.5 ± 4.8^a^    2.7 ± 3.8^b^     −0.2 ± 3.3^c^   **\<0.001**   0.283
  +1/A-Pg angle      −9.6 ± 4.9^a^   −10.4 ± 6.1^a^   −0.5 ± 3.4^b^   **\<0.001**   0.528
  −1/A-Pg distance   2.3 ± 1.3^a^    1.3 ± 1.1^b^     −0.1 ± 1.2^c^   **\<0.001**   0.416
  +1/A-Pg distance   −2.9 ± 1.3^a^   −3.6 ± 2.2^a^    0.2 ± 1.1^b^    **\<0.001**   0.592
  Gl′-Sn-Pg′         −2.1 ± 3.0^a^   −2.0 ± 2.9^a^    0.4 ± 2.3^b^    **\<0.001**   0.182
  Cm-Sn-Ls           1.2 ± 11.0      6.1 ± 10.0       2.9 ± 9.5       0.207         0.032
  Li-E               −0.6 ± 1.8      −0.9 ± 1.9       −0.3 ± 1.6      0.290         0.025
  Ls-E               −1.8 ± 1.8^a^   −1.8 ± 1.3^a^    −0.4 ± 1.2^b^   **\<0.001**   0.205
  Li-S               −0.4 ± 1.8      −0.8 ± 2.0       −0.1 ± 1.6      0.212         0.032
  Ls-S               −1.5 ± 1.7^a^   −1.9 ± 1.1^a^    −0.0 ± 1.4^b^   **\<0.001**   0.261
  OJ                 −5.2 ± 1.6^a^   −4.9 ± 2.6^a^    0.3 ± 1.2^b^    **\<0.001**   0.712

^*∗*^ANOVA with Student-Newman-Keuls post hoc tests. Groups in the same row that share the same superscript letter do not differ significantly.

^*∗∗*^Effect size calculated according to formula: *η*^2^ = between groups sum of squares/total sum of squares. Cohen criteria for interpretation of effect size were used: *η*^2^ = 0.02--0.13 = small effect size, 0.13--0.26 = medium, and \>0.26 = large.

###### 

Structural matrix of canonical discriminant functions.

                      Function      
  ------------------- ------------- ---------------
  Δ+1/A-Pg distance   −0.699^*∗*^   −0.394
  Δ−1/A-Pg distance   0.476^*∗*^    −0.453
  Δ+1/NSL             −0.458^*∗*^   −0.108
  ΔLs-E               −0.298^*∗*^   −0.076
  ΔGl′-Sn-Pog′        −0.277^*∗*^   −0.025
  ΔANB                −0.275^*∗*^   −0.008
  ΔSNB                0.153^*∗*^    0.112
  ΔSNA                −0.131^*∗*^   0.087
  ΔUFH/LFH            −0.120^*∗*^   0.062
  Δ−1/MP              0.210         −0.387^**∗**^
  ΔCo-A               −0.034        −0.383^**∗**^
  ΔMP/NSL             −0.045        −0.351^**∗**^
  ΔCo-Gn              0.080         −0.340^**∗**^
  ΔLi-E               −0.082        −0.150^**∗**^

^*∗*^Largest absolute correlation between each variable and any discriminant function. Variables ordered by absolute size of correlation within function.

[^1]: Academic Editor: Simona Tecco
